A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Survivors of Childhood CancerAlopecia
Interventions
DRUG

Oral Minoxidil

minoxidil at a dose of 0.01 (\<40kg) and 0.02 (≥40kg) mg/kg/day

OTHER

Placebo

placebo for 4 months

Trial Locations (1)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER